Lymphoid antigen cd30

Details Lymphoid antigen cd30 Lymphoid antigen cd30

C - Chemistry, Metallurgy

12

N

C12N 15/12 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61K 49/00 (2006.01) C07H 21/00 (2006.01) C07K 14/705 (2006.01) C07K 19/00 (2006.01) C12N 5/10 (2006.01) C12N 15/62 (2006.01) C12N 15/85 (2006.01)

Patent

CA 2123492

The lymphoid surface antigen CD 30 (Ki-1) that appears during Hodgkin's disease, its protein sequence and corresponding nucleotide sequence, its production by genetic engineering, means for diagnosing and examining Hodgkin's disease, as well as the use of these nucleotide sequences to create transgenic animals are disclosed. The invention makes available means for examining and diagnosing anaplastic large-cell lymphomes that are not based on monoclonal antibodies.

Affiliated with

Also associated with

Rating

Lymphoid antigen cd30 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Lymphoid antigen cd30, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Lymphoid antigen cd30 will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1601011